Analyst Conference Summaries

Biotechnology Investor Aids

Sana Biotechnology
SANA

conference date: November 2, 2022, press release only

Sana Biotechnology a Buy for Potential Cancer Therapies [June 27, 2022 at Seeking Alpha]

2019
  Sana
Biotechnology
Q2 2022
Sana
Biotechnology
Q3 2022
 
  Aug. 4, 2022 Nov. 2, 2022  

Sana Biotechnology (SANA) is a preclinical-stage biotechnology company specializing in cell therapies for blood cancers.

Sana Biotechnology web site


 

Search

More Analyst Conference Pages:

 AGEN
 AGIO
 ALNY
 AMAT
 AMGN
 APRE
 ARWR
 BIIB
 BMY
 CLDX
 CDTX
 DRNA
 EPZM
 GILD
 GLYC
 ILMN
 IMGN
 INCY
 INKT
 INO
 IONS
 MCHP
 MRNA
 PLX
 RETA
 REGN
 RNA
 SAGE
 SGEN
 SYRS
 VBLT
 VSTM
 VRTX
 WBA
       

Disclaimer: My analyst summaries may include both condensations of statements made by company representatives and my own analysis. They are not covered by any warranty. I cannot guarantee anything said by company representatives is true. I try not to make errors, but it is possible. These are my personal notes which I share with other investors and which I use as the basis of my blog and Seeking Alpha articles.

Copyright 2022 William P. Meyers